| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute ischemic heart disease
|
Granger, Christopher B.
|
|
2000
|
139 |
4 |
p. S189-S192
4 p.
|
artikel
|
| 2 |
Alcohol consumption and plasminogen activator inhibitor type 1: The national heart, lung, and blood Institute family heart study
|
Djoussé, Luc
|
|
2000
|
139 |
4 |
p. 704-709
6 p.
|
artikel
|
| 3 |
An FDA perspective on antiarrhythmic drugs in phase II trials
|
Lipicky, Raymond
|
|
2000
|
139 |
4 |
p. S197-S199
3 p.
|
artikel
|
| 4 |
Aortic root dilatation among young competitive athletes: Echocardiographic screening of 1929 athletes between 15 and 34 years of age
|
Kinoshita, Norimitsu
|
|
2000
|
139 |
4 |
p. 723-728
6 p.
|
artikel
|
| 5 |
Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: A mechanism for reducing clinical events?
|
Cohen, Jerome D.
|
|
2000
|
139 |
4 |
p. 734-738
5 p.
|
artikel
|
| 6 |
Benefits of magnesium in acute myocardial infarction: Timing is crucial
|
Gyamlani, Geeta
|
|
2000
|
139 |
4 |
p. 703-
1 p.
|
artikel
|
| 7 |
β-Blockade therapy in chronic heart failure: Diastolic function and mitral regurgitation improvement by carvedilol
|
Capomolla, Soccorso
|
|
2000
|
139 |
4 |
p. 596-608
13 p.
|
artikel
|
| 8 |
β-Blocker improvement in diastolic performance: The yin and yang of ventricular function changes
|
Eichhorn, Eric J.
|
|
2000
|
139 |
4 |
p. 584-586
3 p.
|
artikel
|
| 9 |
Challenges in the conduct and interpretation of phase II (pilot) randomized trials
|
Yusuf, Salim
|
|
2000
|
139 |
4 |
p. S136-S142
7 p.
|
artikel
|
| 10 |
Changes in lipoprotein(a) concentration after orthotopic heart transplantation
|
DeNofrio, David
|
|
2000
|
139 |
4 |
p. 729-733
5 p.
|
artikel
|
| 11 |
Chronic ischemic heart disease
|
Gent, Michael
|
|
2000
|
139 |
4 |
p. S182-S188
7 p.
|
artikel
|
| 12 |
Current definitions of phases of investigation and the role of the FDA in the conduct of clinical trials
|
Temple, Robert
|
|
2000
|
139 |
4 |
p. S133-S135
3 p.
|
artikel
|
| 13 |
Current perspectives on the design of phase II trials of new drugs for the treatment of heart failure
|
Packer, Milton
|
|
2000
|
139 |
4 |
p. S202-S206
5 p.
|
artikel
|
| 14 |
Design and interpretation of equivalence trials
|
Fleming, Thomas R.
|
|
2000
|
139 |
4 |
p. S171-S176
6 p.
|
artikel
|
| 15 |
Design of phase II trials in congestive heart failure
|
DeMets, David L.
|
|
2000
|
139 |
4 |
p. S207-S210
4 p.
|
artikel
|
| 16 |
Detection of angiographically significant coronary artery disease with accelerated intermittent imaging after intravenous administration of ultrasound contrast material
|
Cwajg, Jucyléa
|
|
2000
|
139 |
4 |
p. 675-683
9 p.
|
artikel
|
| 17 |
Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: The EPICAL study
|
Echemann, M.
|
|
2000
|
139 |
4 |
p. 624-631
8 p.
|
artikel
|
| 18 |
Economic end points in phase II trials
|
Mark, Daniel B.
|
|
2000
|
139 |
4 |
p. S155-S157
3 p.
|
artikel
|
| 19 |
Endothelial cell dysfunction correlates differentially with survival in primary and secondary pulmonary hypertension
|
Lopes, Antonio Augusto
|
|
2000
|
139 |
4 |
p. 618-623
6 p.
|
artikel
|
| 20 |
Equivalence and noninferiority trials
|
Siegel, Jay P.
|
|
2000
|
139 |
4 |
p. S166-S170
5 p.
|
artikel
|
| 21 |
Estimating the distribution of quality-adjusted life with censored data
|
Tsiatis, Anastasios A.
|
|
2000
|
139 |
4 |
p. S177-S181
5 p.
|
artikel
|
| 22 |
Impact of Doppler-derived left ventricular diastolic performance on exercise capacity in normal individuals
|
Okura, Hiroyuki
|
|
2000
|
139 |
4 |
p. 716-722
7 p.
|
artikel
|
| 23 |
Introduction
|
Califf, Robert
|
|
2000
|
139 |
4 |
p. S131-S132
2 p.
|
artikel
|
| 24 |
Long-term estrogen replacement therapy is associated with improved exercise capacity in postmenopausal women without known coronary artery disease
|
Redberg, Rita F.
|
|
2000
|
139 |
4 |
p. 739-744
6 p.
|
artikel
|
| 25 |
Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias
|
Fogel, Richard I.
|
|
2000
|
139 |
4 |
p. 690-695
6 p.
|
artikel
|
| 26 |
Medicaid, managed care, and the care of patients hospitalized for acute myocardial infarction
|
Sloan, Frank A.
|
|
2000
|
139 |
4 |
p. 567-576
10 p.
|
artikel
|
| 27 |
Multivessel coronary stenting versus bypass surgery in patients with multivessel coronary artery disease and normal left ventricular function: Immediate and 2-year long-term follow-up
|
Kim, Sang-Wook
|
|
2000
|
139 |
4 |
p. 638-642
5 p.
|
artikel
|
| 28 |
Neurohormonal activation in severe heart failure: Relations to patient death and the effect of treatment with flosequinan
|
Moe, Gordon W.
|
|
2000
|
139 |
4 |
p. 587-595
9 p.
|
artikel
|
| 29 |
Patient-specific dosing of IIb/IIIa antagonists during acute coronary syndromes: Rationale and design of the PARAGON B study
|
Moliterno, David J.
|
|
2000
|
139 |
4 |
p. 563-566
4 p.
|
artikel
|
| 30 |
Peripheral resistance vessel dysfunction in Marfan syndrome
|
Nakamura, Motoyuki
|
|
2000
|
139 |
4 |
p. 661-666
6 p.
|
artikel
|
| 31 |
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors
|
Granger, Christopher B.
|
|
2000
|
139 |
4 |
p. 609-617
9 p.
|
artikel
|
| 32 |
Reproducibility of neointima quantification with motorized intravascular ultrasound pullback in stented coronary arteries
|
Regar, Evelyn
|
|
2000
|
139 |
4 |
p. 632-637
6 p.
|
artikel
|
| 33 |
Right ventricular function in patients with first inferior myocardial infarction: Assessment by tricuspid annular motion and tricuspid annular velocity
|
Alam, Mahbubul
|
|
2000
|
139 |
4 |
p. 710-715
6 p.
|
artikel
|
| 34 |
Role of intracoronary ultrasound after high-pressure stent implantation
|
Choi, James W.
|
|
2000
|
139 |
4 |
p. 643-648
6 p.
|
artikel
|
| 35 |
Sample size and interim analysis issues for dose selection
|
Lee, Kerry L.
|
|
2000
|
139 |
4 |
p. S161-S165
5 p.
|
artikel
|
| 36 |
Select-drop designs in clinical trials
|
Ellenberg, Susan S.
|
|
2000
|
139 |
4 |
p. S158-S160
3 p.
|
artikel
|
| 37 |
Sex differences in coronary artery size assessed by intravascular ultrasound
|
Sheifer, Stuart E.
|
|
2000
|
139 |
4 |
p. 649-652
4 p.
|
artikel
|
| 38 |
Signal-averaged P-wave abnormalities and atrial size in patients with and without idiopathic paroxysmal atrial fibrillation
|
Ishimoto, Naoko
|
|
2000
|
139 |
4 |
p. 684-689
6 p.
|
artikel
|
| 39 |
Statins: Effective antiatherosclerotic therapy
|
Blumenthal, Roger S.
|
|
2000
|
139 |
4 |
p. 577-583
7 p.
|
artikel
|
| 40 |
Surrogate end points in cardiovascular disease trials
|
Fleming, Thomas R.
|
|
2000
|
139 |
4 |
p. S193-S196
4 p.
|
artikel
|
| 41 |
The development of antiarrhythmic drugs
|
Fisher, Lloyd
|
|
2000
|
139 |
4 |
p. S200-S201
2 p.
|
artikel
|
| 42 |
Therapeutic heparin concentrations augment platelet reactivity: Implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximab
|
Mascelli, Mary A.
|
|
2000
|
139 |
4 |
p. 696-703
8 p.
|
artikel
|
| 43 |
The role of clinical nonfatal end points in cardiovascular phase II/III clinical trials
|
O'Connor, Christopher M.
|
|
2000
|
139 |
4 |
p. S143-S154
12 p.
|
artikel
|
| 44 |
Three-dimensional helical computed tomographic angiography in neonates and infants with complex congenital heart disease
|
Kawano, Teruhiro
|
|
2000
|
139 |
4 |
p. 653-660
8 p.
|
artikel
|
| 45 |
Vasodilation with felodipine in chronic asymptomatic aortic regurgitation
|
Søndergaard, Lars
|
|
2000
|
139 |
4 |
p. 667-674
8 p.
|
artikel
|
Tijdschrift beschrijving